Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pamela G Coxson

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Plos One|February 4, 2016
Projected Impact of Salt Restriction on Prevention of Cardiovascular Disease in China: A Modeling StudyMiao Wang, Andrew E Moran, Jing Liu, et al.
Plos One|December 19, 2013
Health benefits of reducing sugar-sweetened beverage intake in high risk populations of California: results from the cardiovascular disease (CVD) policy modelTekeshe A Mekonnen, Michelle C Odden, Pamela G Coxson, et al.
The New England Journal of Medicine|January 22, 2010
Projected effect of dietary salt reductions on future cardiovascular diseaseKirsten Bibbins-Domingo, Glenn M Chertow, Pamela G Coxson, et al.
Annals of Internal Medicine|April 21, 2015
Cost-effectiveness and population impact of statins for primary prevention in adults aged 75 years or older in the United StatesMichelle C Odden, Mark J Pletcher, Pamela G Coxson, et al.
Circulation. Cardiovascular Quality and Outcomes|January 16, 2014
Cost-effectiveness of optimal use of acute myocardial infarction treatments and impact on coronary heart disease mortality in ChinaMiao Wang, Andrew E Moran, Jing Liu, et al.
The New England Journal of Medicine|June 7, 2002
Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart diseaseJean-Michel Gaspoz, Pamela G Coxson, Paula A Goldman, et al.
Journal of General Internal Medicine|March 10, 2015
Simulating Strategies for Improving Control of Hypertension Among Patients with Usual Source of Care in the United States: The Blood Pressure Control ModelValy Fontil, Kirsten Bibbins-Domingo, Dhruv S Kazi, et al.
American Journal of Hypertension|May 14, 2016
Comparative Cost-Effectiveness of Hypertension Treatment in Non-Hispanic Blacks and Whites According to 2014 Guidelines: A Modeling StudyEshan Vasudeva, Nathalie Moise, Chen Huang, et al.
Circulation|July 9, 2017
Evaluating the Impact and Cost-Effectiveness of Statin Use Guidelines for Primary Prevention of Coronary Heart Disease and StrokeDavid J Heller, Pamela G Coxson, Joanne Penko, et al.
Circulation|December 7, 2011
Using stress testing to guide primary prevention of coronary heart disease among intermediate-risk patients: a cost-effectiveness analysisBenjamin Z Galper, Andrew Moran, Pamela G Coxson, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Plos One|February 4, 2016
Projected Impact of Salt Restriction on Prevention of Cardiovascular Disease in China: A Modeling StudyMiao Wang, Andrew E Moran, Jing Liu, et al.
Plos One|December 19, 2013
Health benefits of reducing sugar-sweetened beverage intake in high risk populations of California: results from the cardiovascular disease (CVD) policy modelTekeshe A Mekonnen, Michelle C Odden, Pamela G Coxson, et al.
The New England Journal of Medicine|January 22, 2010
Projected effect of dietary salt reductions on future cardiovascular diseaseKirsten Bibbins-Domingo, Glenn M Chertow, Pamela G Coxson, et al.
Annals of Internal Medicine|April 21, 2015
Cost-effectiveness and population impact of statins for primary prevention in adults aged 75 years or older in the United StatesMichelle C Odden, Mark J Pletcher, Pamela G Coxson, et al.
Circulation. Cardiovascular Quality and Outcomes|January 16, 2014
Cost-effectiveness of optimal use of acute myocardial infarction treatments and impact on coronary heart disease mortality in ChinaMiao Wang, Andrew E Moran, Jing Liu, et al.
The New England Journal of Medicine|June 7, 2002
Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart diseaseJean-Michel Gaspoz, Pamela G Coxson, Paula A Goldman, et al.
Journal of General Internal Medicine|March 10, 2015
Simulating Strategies for Improving Control of Hypertension Among Patients with Usual Source of Care in the United States: The Blood Pressure Control ModelValy Fontil, Kirsten Bibbins-Domingo, Dhruv S Kazi, et al.
American Journal of Hypertension|May 14, 2016
Comparative Cost-Effectiveness of Hypertension Treatment in Non-Hispanic Blacks and Whites According to 2014 Guidelines: A Modeling StudyEshan Vasudeva, Nathalie Moise, Chen Huang, et al.
Circulation|July 9, 2017
Evaluating the Impact and Cost-Effectiveness of Statin Use Guidelines for Primary Prevention of Coronary Heart Disease and StrokeDavid J Heller, Pamela G Coxson, Joanne Penko, et al.
Circulation|December 7, 2011
Using stress testing to guide primary prevention of coronary heart disease among intermediate-risk patients: a cost-effectiveness analysisBenjamin Z Galper, Andrew Moran, Pamela G Coxson, et al.
Pageof 4